Quick Search

 

 


 

 

Result Summary for TP552001

Result Summary
Protocol ID: TP552001
Clinical Study ID: TP552001
Official Title: A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of a New Chemical Entity for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis.
Phase: Phase 3
Study Indications or Diseases:
  • Nausea and Vomiting, Postoperative
Generic Name: ondansetron
Trade/Product Name: zofran;zofran
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.